These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 27052127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D, Burniston M, Moya E, Parkin A, Smye S, Robinson P, Littlewood J.
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [Abstract] [Full Text] [Related]

  • 3. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis.
    McCormack P, McNamara PS, Southern KW.
    J Cyst Fibros; 2011 Sep; 10(5):343-9. PubMed ID: 21620782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial.
    Dentice RL, Elkins MR, Dwyer GM, Bye PTP.
    BMC Pulm Med; 2018 Jan 08; 18(1):3. PubMed ID: 29310638
    [Abstract] [Full Text] [Related]

  • 6. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T, Mills N, Whitaker P.
    Paediatr Respir Rev; 2013 Jun 08; 14(2):98-9. PubMed ID: 23583049
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects.
    Lenney W, Edenborough F, Kho P, Kovarik JM.
    J Cyst Fibros; 2011 Jan 08; 10(1):9-14. PubMed ID: 20884302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS.
    Sands D, Sapiejka E, Gąszczyk G, Mazurek H, T100 Study Group.
    J Cyst Fibros; 2014 Dec 08; 13(6):653-60. PubMed ID: 24836961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    Clavel A, Boulaméry A, Bosdure E, Luc C, Lanteaume A, Gorincour G, Stremler-Lebel N, Sarles J, Andrieu V, Dubus JC.
    J Cyst Fibros; 2007 Apr 08; 6(2):137-43. PubMed ID: 16839826
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH, O'Doherty MJ, Graham A, Page CJ, Blower P, Geddes DM, Nunan TO.
    Thorax; 1991 Oct 08; 46(10):717-21. PubMed ID: 1750018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial.
    Dentice RL, Elkins MR, Verschuer J, Eberl S, Dwyer G, Bye PTP.
    BMC Pulm Med; 2019 Jul 16; 19(1):128. PubMed ID: 31311524
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.